_the-use-of-sodium-glucose-cotransporter-2-sglt2-inhibitors-in-stemi-weekly-research-conference-preview-1.jpg "The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference from sgkt2 Video Screenshot Preview 1")
Gallery_the-use-of-sodium-glucose-cotransporter-2-sglt2-inhibitors-in-stemi-weekly-research-conference-preview-3.jpg "The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference from sgkt2 Video Screenshot Preview 3")
Gallery_the-use-of-sodium-glucose-cotransporter-2-sglt2-inhibitors-in-stemi-weekly-research-conference-preview-hqdefault.jpg "The use of sodium-glucose cotransporter-2 (SGLT2) inhibitors in STEMI - Weekly Research Conference from sgkt2 Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 49 minutes 58 seconds
👁 View: 613 times
Play Audio:👁 View: 613 times
Description:
University of Ottawa Heart Institute
University of Ottawa Heart Institute
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.webp "Harvard Medical School Continuing Education")
_when-should-we-use-sglt2-inhibitors.webp "The France Foundation")
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.webp "Cátedra USC Semergen")
⏲ 1 hour 5 minutes 21 seconds 👁 1.4K
_benefits-of-sglt2-inhibitors-and-glp-1-receptor-agonists.webp "Harvard Medical School Continuing Education")
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.webp "Mayo Proceedings")
⏲ 5 minutes 7 seconds 👁 151
_9234sglt2-inhibitors-mechanisms-of-behind-the-mortality-benefit9234-presented-by-amy-li.webp "University of Colorado | Department of Medicine")
⏲ 56 minutes 22 seconds 👁 1.1K
_sglt2-inhibitors-explained-in-3-minutes.webp "Drug Matters")
_introduction-to-sglt2-inhibition.webp "Boehringer Ingelheim")
_choosing-sglt2-inhibitors-vs-glp-1-receptor-agonists.jpg)
_when-should-we-use-sglt2-inhibitors.jpg)
_sglt2-inhibitors-in-heart-failure-new-analyses-and-recent-updates.jpg)
_benefits-of-sglt2-inhibitors-and-glp-1-receptor-agonists.jpg)
_sglt2-inhibitors-are-associated-with-reduced-cv-disease-in-type-2-diabetes.jpg)
_9234sglt2-inhibitors-mechanisms-of-behind-the-mortality-benefit9234-presented-by-amy-li.jpg)
_sglt2-inhibitors-explained-in-3-minutes.jpg)
_introduction-to-sglt2-inhibition.jpg)
![[+]](/images/menu.gif){kind=small}